Antigen modulation confers protection to red blood cells from antibody through Fcγ receptor ligation

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5013-5025

  Stowell, Sean R ^a   Liepkalns, Justine S ^a   Hendrickson, Jeanne E ^a   Girard Pierce, Kathryn R ^a   Smith, Nicole H ^a   Maridith Arthur, C ^a   Zimring, James C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; COMPLEMENT COMPONENT C3; FC RECEPTOR; MEMBRANE ANTIGEN; COMPLEMENT; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGENIC MODULATION; ARTICLE; CELL PROTECTION; CELL SURFACE; CELL SURVIVAL; COMPLEMENT FIXATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE CULTURE; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIGENIC MODULATION; ANTIGENS, SURFACE; AUTOANTIBODIES; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTES; IMMUNOGLOBULIN G; ISOANTIBODIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IGG;

EID: 84887479982     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300885     Document Type: Article

References (46)

1. Goodnow, C. C., J. Sprent, B. Fazekas De St Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435:590-597.
2. Hogquist, K. A., T. A. Baldwin, and S. C. Jameson. 2005. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 5:772-782.
3. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621.
4. Walker, L. S., and A. K. Abbas. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19.
5. Toscano, M. A., G. A. Bianco, J. M. Ilarregui, D. O. Croci, J. Correale, J. D. Hernandez, N. W. Zwirner, F. Poirier, E. M. Riley, L. G. Baum, and G. A. Rabinovich. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8:825-834.
6. Cerliani, J. P., S. R. Stowell, I. D. Mascanfroni, C. M. Arthur, R. D. Cummings, and G. A. Rabinovich. 2011. Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity. J. Clin. Immunol. 31:10-21.
7. Stowell, S. R., S. Karmakar, C. M. Arthur, T. Ju, L. C. Rodrigues, T. B. Riul, M. Dias-Baruffi, J. Miner, R. P. McEver, and R. D. Cummings. 2009. Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Mol. Biol. Cell 20:1408-1418.
8. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9:729-740.
9. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
10. Hiruma, K., H. Nakamura, P. A. Henkart, and R. E. Gress. 1992. Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes. J. Exp. Med. 175:863-868.
11. Müller, C., and J. Tschopp. 1994. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin. J. Immunol. 153:2470-2478.
12. Lehmann, C., M. Zeis, N. Schmitz, and L. Uharek. 2000. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood 96:594-600.
13. Cyster, J. G., K. M. Ansel, V. N. Ngo, D. C. Hargreaves, and T. T. Lu. 2002. Traffic patterns of B cells and plasma cells. Adv. Exp. Med. Biol. 512:35-41.
14. Ravetch, J. V., and R. A. Clynes. 1998. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16:421-432.
15. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
16. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity 24:19-28.
17. Ferreira, V. P., and M. K. Pangburn. 2007. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood 110:2190-2192.
18. Moller, G. 1964. Isoantibody-induced cellular resistance to immune haemolysis in vivo and in vitro. Nature 202:357-359.
19. Kao, I., and D. B. Drachman. 1977. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196:527-529.
20. Tzartos, S. J., D. Sophianos, and A. Efthimiadis. 1985. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera. J. Immunol. 134:2343-2349.
21. Boylan, B., H. Chen, V. Rathore, C. Paddock, M. Salacz, K. D. Friedman, B. R. Curtis, M. Stapleton, D. K. Newman, M. L. Kahn, and P. J. Newman. 2004. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibodymediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood 104:1350-1355.
22. Vengelen-Tyler, V., B. Gonzalez, G. Garratty, C. Kruppe, C. L. Johnson, K. A. Mueller, and W. L. Marsh. 1987. Acquired loss of red cell Kell antigens. Br. J. Haematol. 65:231-234.
23. Bach, F. H., C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada, T. Miyatake, H. Winkler, A. Badrichani, D. Candinas, and W. W. Hancock. 1997. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat. Med. 3:196-204.
24. Park, W. D., J. P. Grande, D. Ninova, K. A. Nath, J. L. Platt, J. M. Gloor, and M. D. Stegall. 2003. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am. J. Transplant. 3:952-960.
25. Beum, P. V., A. D. Kennedy, M. E. Williams, M. A. Lindorfer, and R. P. Taylor. 2006. The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes. J. Immunol. 176:2600-2609.
26. Mohandas, N., and P. G. Gallagher. 2008. Red cell membrane: past, present, and future. Blood 112:3939-3948.
27. Desmarets, M., C. M. Cadwell, K. R. Peterson, R. Neades, and J. C. Zimring. 2009. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 114:2315-2322.
28. Liepkalns, J. S., E. A. Hod, S. R. Stowell, C. M. Cadwell, S. L. Spitalnik, and J. C. Zimring. 2012. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion 52:2631-2645.
29. Stowell, S. R., K. L. Henry, N. H. Smith, K. E. Hudson, G. R. Halverson, J. C. Park, A. M. Bennett, K. R. Girard-Pierce, C. M. Arthur, S. T. Bunting, J. C. Zimring, and J. E. Hendrickson. 2013. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood 122:1494-1504
30. Liepkalns, J. S., C. M. Cadwell, S. R. Stowell, E. A. Hod, S. L. Spitalnik, and J. C. Zimring. 2013. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion 53:1319-1327.
31. Stowell, S. R., N. H. Smith, J. C. Zimring, X. Fu, A. F. Palmer, J. Fontes, U. Banerjee, and M. H. Yazer. 2013. Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization. Transfusion 2013 Feb. 5. doi: 10.1111/trf.12106.
32. Krisinger, M. J., V. Goebeler, Z. Lu, S. C. Meixner, T. Myles, E. L. Pryzdial, and E. M. Conway. 2012. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood 120:1717-1725.
33. Wong, K., S. Bumpstead, L. Van Der Weyden, L. G. Reinholdt, L. G. Wilming, D. J. Adams, and T. M. Keane. 2012. Sequencing and characterization of the FVB/NJ mouse genome. Genome Biol. 13:R72.
34. Beum, P. V., A. D. Kennedy, Y. Li, A. W. Pawluczkowycz, M. E. Williams, and R. P. Taylor. 2004. Complement activation and C3b deposition on rituximabopsonized cells substantially blocks binding of phycoerythrin-labeled antimouse IgG probes to rituximab. J. Immunol. Methods 294:37-42.
35. Hod, E. A., C. M. Cadwell, J. S. Liepkalns, J. C. Zimring, S. A. Sokol, D. A. Schirmer, J. Jhang, and S. L. Spitalnik. 2008. Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood 112:891-894.
36. Stowell, S. R., A. M. Winkler, C. L. Maier, C. M. Arthur, N. H. Smith, K. R. Girard-Pierce, R. D. Cummings, J. C. Zimring, and J. E. Hendrickson. 2012. Initiation and regulation of complement during hemolytic transfusion reactions. Clin. Dev. Immunol. 2012:307093.
37. Girard-Pierce, K. R., S. R. Stowell, N. H. Smith, C. M. Arthur, H. C. Sullivan, J. E. Hendrickson, and J. C. Zimring. 2013. A novel role for C3 in antibodyinduced red blood cell clearance and antigen modulation. Blood. 122:1793-1801.
38. Williamson, L. M., J. Poole, C. Redman, N. Clark, Y. W. Liew, D. C. Russo, S. Lee, M. E. Reid, and A. J. Black. 1994. Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopenia. Br. J. Haematol. 87:805-812.
39. Victoria, E. J., S. W. Pierce, M. J. Branks, and S. P. Masouredis. 1990. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein. J. Lab. Clin. Med. 115:74-88.
40. Schirmer, D. A., S. C. Song, J. P. Baliff, S. O. Harbers, R. A. Clynes, A. Krop-Watorek, G. R. Halverson, M. Czerwinski, and S. L. Spitalnik. 2007. Mouse models of IgG- and IgM-mediated hemolysis. Blood 109:3099-3107.
41. Brown, D. L., P. J. Lachmann, and J. V. Dacie. 1970. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin. Exp. Immunol. 7:401-421.
42. Nimmerjahn, F., A. Lux, H. Albert, M. Woigk, C. Lehmann, D. Dudziak, P. Smith, and J. V. Ravetch. 2010. FcgRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc. Natl. Acad. Sci. USA 107:19396-19401.
43. Hogarth, P. M. 2002. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 14:798-802.
44. Hendrickson, J. E., T. E. Chadwick, J. D. Roback, C. D. Hillyer, and J. C. Zimring. 2007. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 110:2736-2743.
45. Sibéril, S., C. A. Dutertre, W. H. Fridman, and J. L. Teillaud. 2007. FcgammaR: The key to optimize therapeutic antibodies? Crit. Rev. Oncol. Hematol. 62:26
46. Turgeon, N. A., A. D. Kirk, and N. N. Iwakoshi. 2009. Differential effects of donor-specific alloantibody. Transplant. Rev. (Orlando) 23:25-33.